Latest Articles

Publication Date
Vaginal Sildenafil Citrate in Assisted Reproduction: Rethinking Endometrial Optimization Through Targeted Vasodilation – Nice Order Now - viagra8ordernow.com

Vaginal Sildenafil Citrate in Assisted Reproduction: Rethinking Endometrial Optimization Through Targeted Vasodilation – Nice Order Now viagra8ordernow.com

Published: Dec. 10, 2025, 3:53 a.m.
NICE recommends treatment for primary advanced or recurrent endometrial cancer - Pf Media

NICE recommends treatment for primary advanced or recurrent endometrial cancer Pf Media

Published: Nov. 26, 2025, 4:10 p.m.
Broader NICE recommendation for GSK’s Jemperli - The Pharma Letter

Broader NICE recommendation for GSK’s Jemperli The Pharma Letter

Published: Nov. 25, 2025, 4:20 p.m.
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer NAVLIN DAILY

Published: Nov. 25, 2025, 2:06 p.m.
Sildenafil Citrate, Natural Killer Cells, and Recurrent Miscarriage: A Novel Immunovascular Approach to Reproductive Failure – Nice Order Now - viagra8ordernow.com

Sildenafil Citrate, Natural Killer Cells, and Recurrent Miscarriage: A Novel Immunovascular Approach to Reproductive Failure – Nice Order Now viagra8ordernow.com

Published: Sept. 15, 2025, 11:08 p.m.
Fertility Clinics Must End Unproven Treatments, Says NICE - Medscape

Fertility Clinics Must End Unproven Treatments, Says NICE Medscape

Published: Sept. 10, 2025, 6 p.m.
What makes NICE stock price move sharply - Free Earnings Play Trade Plan With Alerts - Newser

What makes NICE stock price move sharply - Free Earnings Play Trade Plan With Alerts Newser

Published: Aug. 8, 2025, 5:49 p.m.
MSD receives NICE recommendation for Keytruda in advanced endometrial cancer - PMLiVE

MSD receives NICE recommendation for Keytruda in advanced endometrial cancer PMLiVE

Published: Aug. 8, 2025, 11:07 a.m.
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes

NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes

Published: Aug. 7, 2025, 9:15 a.m.
NICE approves first immunotherapy combination for endometrial cancer - Wired Gov

NICE approves first immunotherapy combination for endometrial cancer Wired Gov

Published: Aug. 6, 2025, 1:13 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!